Records containing: Retinal Dystrophies
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality
-
CLINICAL_TRIALS study record update · 2026-04-13A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation-Associated Retinal Dystrophy
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1 Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy
-
CLINICAL_TRIALS study record update · 2026-03-31Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
-
CLINICAL_TRIALS study record update · 2025-12-10Color Vision Loss Progression in IRD Patients: Retinal Structural Changes Correlations, and a Novel Color Discrimination Test for Extreme Low Vision Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-02A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 (30 μg and 75 μg) Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 in the PLATYPUS Study (Protocol # VP001-101) or WALLABY Study (Protocol # VP001-102) for a Minimum of 8 Weeks
-
CLINICAL_TRIALS study record update · 2025-10-06Ultracompact Hand-Held Swept-Source Optical Coherence Tomography (SS-HH-OCT) as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)
-
CLINICAL_TRIALS study record update · 2025-09-29The Effects of Disulfiram on Visual Acuity in Patients With Retinal Degeneration
-
CLINICAL_TRIALS study record update · 2025-07-31Qualification for Cone-Optogenetics (EyeConic)
-
CLINICAL_TRIALS study record update · 2025-07-10iPS Cells of Patients for Models of Retinal Dystrophies
-
CLINICAL_TRIALS study record update · 2025-03-24Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE Study
-
CLINICAL_TRIALS study record update · 2025-01-08Observational, Non-Interventional Study to Determine the Operational Feasibility and Measurement Properties of Endpoints in Patients with Retinal Degeneration
-
CLINICAL_TRIALS study record update · 2024-08-21Performance of Optimized Long-wavelength Fundus Autofluorescence Imaging in Patients With Retinal Diseases
-
CLINICAL_TRIALS study record update · 2024-04-25Objective Perimetry in Normal Subjects,Glaucoma Patients and Retinal Dystrophy Patients
-
CLINICAL_TRIALS study record update · 2024-03-22A Phase 2b Randomized, Double-Masked, Sham-Controlled, Study to Evaluate the Efficacy and Safety of Intravitreal Injection of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
-
CLINICAL_TRIALS study record update · 2024-03-06Observational, Follow-up Study of Adaptive Optics Retinal Imaging in Controls and During Retinal or General Diseases
-
CLINICAL_TRIALS study record update · 2022-05-06A Prospective First-In-Human Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa (adRP) Due to the P23H Mutation in the RHO Gene
-
CLINICAL_TRIALS study record update · 2022-04-12Combined Coaxial Optical Coherence Tomography System to Image the Retina and Choroidal Structures and Estimate Tissue Reflectivity in Healthy and Diseased Retinas
-
CLINICAL_TRIALS study record update · 2022-03-25An Open-Label, Dose Escalation and Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Tolerability of Sepofarsen in Pediatric Subjects <8 Years of Age With Leber Congenital Amaurosis Type 10 (LCA10) Due to the c.2991 +1655A>G (p.Cys998X) Mutation.
-
CLINICAL_TRIALS study record update · 2019-10-09Optical Head-Mounted Display Technology for Low Vision Rehabilitation
-
CLINICAL_TRIALS study record update · 2019-09-23Efficacy and Safety of Intravitreal Ranibizumab (Lucentis®) Injection in the Treatment of Non-leaking Macular Cysts in Patients With Retinal Dystrophy.